EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

Miguel Quiralte, Arantzazu Barquín, Mónica Yagüe-Fernández, Paloma Navarro, Tatiana P Grazioso, Elena Sevillano-Fernández, Juan F Rodriguez-Moreno, Alejandra Balarezo-Saldivar, Héctor Peinado, Elena Izquierdo, Carlos Millán, Irene López-Carrasco und 5 weitere

Journal of Clinical Investigation · 15.05.2024 · 134 (10)

DOI: 10.1172/jci176161 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.04.2024. Verfasst von Miguel Quiralte und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Innovation in Oncology, Clara Campal Comprehensive Cancer Centre (HM CIOCC), HM Sanchinarro University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Extracellular Vesicles, Ascitic Fluid, Proteomics. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 10th Jan Vermorken Gynecological Cancer Research Grant. GEICO, Andres Poveda GEICO Translational Research Grant 2022. GEICO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-derived small extracellular vesicles (sEVs) are capable of modifying the tumor microenvironment and promoting tumor progression. Ovarian cancer (OvCa) is a lethal malignancy that preferentially spreads through the abdominal cavity. Thus, the secretion of such vesicles into the peritoneal fluid could be a determinant factor in the dissemination and behavior of this disease. We designed a prospective observational study to assess the impact of peritoneal fluid–derived sEVs (PFD-sEVs) in OvCa clinical outcome. For this purpose, 2 patient cohorts were enrolled: patients with OvCa who underwent a diagnostic or cytoreductive surgery and nononcological patients, who underwent abdominal surgery for benign gynecological conditions and acted as the control group. Systematic extraction of PFD-sEVs from surgical samples enabled us to observe significant quantitative and qualitative differences associated with cancer diagnosis, disease stage, and platinum chemosensitivity. Proteomic profiling of PFD-sEVs led to the identification of molecular pathways and proteins of interest and to the biological validation of S100A4 and STX5. In addition, unsupervised analysis of PFD-sEV proteomic profiles in high-grade serous ovarian carcinomas (HGSOCs) revealed 2 clusters with different outcomes in terms of overall survival. In conclusion, comprehensive characterization of PFD-sEV content provided a prognostic value with potential implications in HGSOC clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsExtracellular VesiclesAscitic FluidProteomicsHumansFemaleMiddle AgedAgedProspective StudiesNeoplasm ProteinsAdult

Stichwörter der Autor:innen

CancerObstetrics/gynecologyOncologyProteomics

Substanzen

Neoplasm Proteins

Autor:innen und Institutionen

  • Laboratory of Innovation in Oncology, Clara Campal Comprehensive Cancer Centre (HM CIOCC), HM Sanchinarro University Hospital, Madrid, Spain.
  • Institute of Applied Molecular Medicine, Faculty of Medicine, Universidad San Pablo-CEU, Alcorcón, Madrid, Spain.
  • HM CIOCC, HM Sanchinarro University Hospital, Madrid, Spain.
  • Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Centre, Madrid, Spain.
  • Gynecologic Unit, HM Montepríncipe University Hospital, Boadilla del Monte, Madrid, Spain.
  • Department of Pathological Anatomy, Therapeutic Targets Laboratory, HM Sanchinarro University Hospital, Madrid, Spain.

Förderung

  • 10th Jan Vermorken Gynecological Cancer Research Grant. GEICO
  • Andres Poveda GEICO Translational Research Grant 2022. GEICO

Zitieren

APA

Quiralte, M., Barquín, A., Yagüe-Fernández, M., Navarro, P., Grazioso, T. P., Sevillano-Fernández, E., Rodriguez-Moreno, J. F., Balarezo-Saldivar, A., Peinado, H., Izquierdo, E., Millán, C., López-Carrasco, I., Prieto, M., Madurga, R., Fernández-Miranda, I., Ruiz-Llorente, S., & García-Donas, J. (2024). Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer. Journal of Clinical Investigation, 134(10). https://doi.org/10.1172/jci176161

Vancouver

Quiralte M, Barquín A, Yagüe-Fernández M, Navarro P, Grazioso TP, Sevillano-Fernández E, et al. Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer. Journal of Clinical Investigation. 2024;134(10). doi:10.1172/jci176161

BibTeX
@article{Quiralte2024,
  author = {Quiralte, Miguel and Barquín, Arantzazu and Yagüe-Fernández, Mónica and Navarro, Paloma and Grazioso, Tatiana P and Sevillano-Fernández, Elena and Rodriguez-Moreno, Juan F and Balarezo-Saldivar, Alejandra and Peinado, Héctor and Izquierdo, Elena and Millán, Carlos and López-Carrasco, Irene and Prieto, Mario and Madurga, Rodrigo and Fernández-Miranda, Ismael and Ruiz-Llorente, Sergio and García-Donas, Jesús},
  title = {Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {10},
  doi = {10.1172/jci176161}
}
Kostenlos starten →